- A
- A
- A
Oral Chelation—The Strongest Natural Treatment for Your Heart, Arteries, Memory, and More—Has Just Become Even More Effective
Stay Healthy and Active With EDTA Chelation!
Every year, nearly six million Americans end up in the hospital, suffering with disease that is largely preventable, reversible—even curable.
-Sponsored Ads-
But it doesn't have to be that way. You don't have to be a victim of CVD. Nor do you have to submit to dangerous, expensive surgery or heart drugs.
What heart disease really does to your body … and how you can reverse it
If you or a loved one suffers from any form of CVD, here is the simple— but too often overlooked—truth about how this prevalent killer operates. What the public at large tends not to realize—and what your doctor has likely failed to explain to you—is that the primary precursor to heart disease, atherosclerosis (hardened arteries) is not a localized injury. It's a systemic condition. In other words, atherosclerosis is present not only in the coronary arteries, but also in the brain, lungs, kidneys, and legs.1
What's more, the blockages that lead to atherosclerosis can occur not only in the larger vessels—the vessels that can be seen and manipulated by surgeons and cardiologists—but in the smaller blood vessels as well. It is in these smaller blood vessels, the capillaries, that the oxygen exchange to the tissues takes place. You can protect that critical lifeline of oxygen that feeds and sustains the organs and tissues throughout your body—including your heart. There exists today a treatment that removes plaque and restores blood flow throughout the entire arterial system, treating the micro as well as the macro vessels. It's called EDTA chelation, available via intravenous and oral supplementation. You should consider chelation therapy—safe, inexpensive, and proven effective—if you have a family history of CVD or existing CVD. You should also consider chelation if you simply want to do everything within your power to prevent CVD … and the potentially disastrous effects of the conventional medical treatments for this deadly disease.
Treating your heart the conventional way—with plastic balloons and cabbages …
Traditional medicine approaches heart disease primarily in one of two ways. The first is to ream out clogged arteries or flatten deposits in the vessels with angioplasty. This procedure does have some risk for heart attack or making the blockage even worse.2 Many of the blockages return to their original severity within a year.
The second way is to cut away the clogged section or sections of the artery and replace it with a new section or sections of arteries grafted from other places in the body. This procedure is called a coronary artery bypass graft, or CABG… known in the medical profession as "cabbage." An appropriate nickname, perhaps, as it's also a nickname for money… and CABG, the most frequently performed surgery in the United States, costs up to $50,000 per procedure.
If your doctor has recommended CABG to you or a loved one, you should know that the average mortality for CABG surgery is 4% to 10%.34 And a common "side effect" after the procedure is cerebral dysfunction—memory loss and mental decline.5
But it saves lives…right? Not according to the New England Journal of Medicine. According to a pivotal study published in this prestigious medical journal, CABG, compared with less invasive and risky medical therapy, "appears neither to prolong life nor to prevent myocardial infarction [heart attack] in patients who have mild angina [chest pain] or who are asymptomatic [suffer no pain] after infarction in the five-year period after coronary angiography." 6
The failure of standard medical treatments to heal heart patients doesn't really come as a surprise. Fact is, any treatment that fails to support the circulation throughout your entire body is likely to fail you—and your health—in the long run. But cardiovascular surgery, and other conventional heart treatments are enormously—almost unimaginably—profitable. CABG alone generates as much as $18.4 billion per year. 7 Drugs for reducing cholesterol, lowering high blood pressure, and normalizing heart rhythm bring the pharmaceutical industry hundreds of millions of dollars each year.
Meanwhile, chelation therapy is a potent, safe, inexpensive and virtually risk-free heart and circulation treatment … and recent research suggests it may in fact, be the single most powerful treatment for CVD.
A godsend for victims of heavy metal poisoning … and those who want to prevent and reverse atherosclerosis
In the days after World War II, men who worked in battery factories or painted ships with lead-based paint began coming down with lead poisoning from their high exposure in these jobs. A safe, harmless chemical called EDTA was found to be extremely effective for removing the lead from the men's bodies—an effective cure for lead poisoning. But something else happened to many of the men who were treated with EDTA: they enjoyed an apparent reduction in symptoms of heart disease.
How does it work? Let's start with a few basics.
A chelate is a chemical compound in which the central atom (usually a metal ion) is attached to neighboring atoms by at least two bonds in such a way as to form a ring structure. Chelating is the process in which the metal ion reacts with another molecule to form the chelate. EDTA (ethylenediaminetetraacetic acid) is an amino acid. It was synthesized in Germany in 1935, and first patented in the U.S. in 1941. Chelation therapy itself can be understood simply as the removal of calcium deposits (from your arteries, where you don't want them) and other harmful minerals that promote blood clotting and atherosclerosis. Since these harmful deposits are also known to cause excessive free radical production, EDTA chelation also functions as a powerful free radical buster … protecting cell membranes, DNA, enzyme systems, and lipoproteins from the destructive effects of these ravenous molecules. Some experts believe that the primary benefits of chelation are due to its free radical-fighting effects.8 And perhaps one of the most compelling, but often overlooked, explanations for chelation's anti-aging, energizing effects is that EDTA "resuscitates" your cells' mitochondria. Mitochondria are the "power plants" of every cell in the body—the site in which the energy-producing ATP is generated. Without ATP, life can not exist.9 Loss of mitochondrial function has long been considered to be one of the primary causes of the aging process.10
But don't look to the mainstream community for the truth about this powerful, life-saving therapy
The American Heart Association (AHA) recognizes chelation therapy as a treatment for heavy metal poisoning. The AHA admits that EDTA, injected into the blood, will bind the metals and allow them to be removed from the body in the urine. In fact, EDTA is the standard FDA approved treatment for lead, mercury, aluminum, and cadmium poisoning.
But neither the FDA nor the AMA acknowledges that chelation appears to be one of the most powerful—yet least expensive … and safest—treatments for heart disease in existence. The bottom line: chelation therapy, which costs only $2,000 to $4,000 per course—represents a significant threat to one of the largest income streams for conventional practitioners. Clearly, if EDTA chelation had a large pharmaceutical company advocating its use … it would, at the very least, be integrated into the standard, AMA-approved treatment for heart disease. But the patent for EDTA ran out nearly 30 years ago. No patent means no profits. And if the medical industry can't profit from chelation … this safe, inexpensive, powerful treatment … it may as well not exist.
50+ years of proof: Chelation could save hundreds of thousands of lives … every year
From its earliest clinical tests, chelation therapy has consistently demonstrated a remarkable ability to cleanse the system of metals and other deposits that lead to so-called age-related disease. In 1955, research conducted at the Providence Hospital in Detroit, Michigan, found that EDTA dissolves "metastatic calcium"—i.e., calcium that has been deposited where it is not wanted. Namely, arteries, joints, kidneys, and even the bones of the inner ear. In other words, chelation therapy appeared to be a powerful antidote to—and preventative against—atherosclerosis, arthritis, kidney stones, and otosclerosis (hearing loss related to the calcification of the bones in the ear).11
Nineteen out of 20 heart patients enjoyed measurable improvement in energy and activity level
The first systematic study of EDTA in people with atherosclerosis was published in 1956. Twenty patients with confirmed heart disease were given a series of 30 EDTA treatments intravenously. Nineteen of the patients experienced improvement, as measured by an increase in physical activity.12
Editor's Note:
The natural health solutions described in this article are available through many on-line retailers including those listed below. By clicking these links you help support the important alternative health research we provide.
Visit International Antiaging-Systems for hard to find therapies. They specialize in Tomorrow's Treatments Today™.
Visit www.amazon.com – a great way to find competitive deals on supplements offered by many different manufacturers.
Visit www.hfn-usa.com – when commitment to quality and freshness is important, this factory direct solution is preferred by many of our readers.
This article is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a physician before embarking on a dietary supplement program.
References
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library, http://www.vrp.com.
-
Parisi AF, Folland ED, Hartigan PA. Comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16.
-
Edmunds LH, Stephenson LW, Edie RN, Ratcliffe MB. Open-heart surgery in octogenarians. N Engl J Med 1988; 319:131-136.
-
CASS Principal Investigators and the Associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery: Survival data. Circulation. 1983; 68: 939-950.
-
Arom KV, Cohen DE, Strobl FT. Effect of intraoperative intervention on neurological outcome based on electroencephalographic monitoring during cardiopulmonary bypass.Ann Thorac Surg. 1988; 48:476-483.
-
Arom KV, Cohen DE, Strobl FT. Effect of intraoperative intervention on neurological outcome based on electroencephalographic monitoring during cardiopulmonary bypass.Ann Thorac Surg. 1988; 48:476-483.
-
Center for Disease control website: http://www.cdc.gov
-
Cranton, Elmer. Bypassing Bypass (2d Ed). Medex Publishers, Trout Dale, VA 24378-0044, 1992.
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library.http://www.vrp.com.
-
Harman, D. The biologic clock: The mitochondria? J Am Geriatr Soc, 1972, 20: 145-147.
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library,http://www.vrp.com.
-
Clarke NE, Clarke CN, Mosher RE. Treatment of angina pectoris with disodium ethelyne diamene tetraacetic acid. Am J Med Sci. 1956: December: 654-666.
-
Meltzer LE, Ural E, Kitchell JR. The treatment of coronary artery heart disease with disodium EDTA. In: Seven M, ed. Metal-Binding in Medicine, Philadelphia: JB Lippincott: 1960.
-
These papers, The correlation between EDTA Chelation Therapy and improvement in cardiovascular function: A Meta-Analysis, and EDTA Chelation Treatment for vascular disease: A Meta-Analysis using unpublished data, both by L.T. Chappell and J.P. Stahl, were published in the Journal of Advancement in Medicine in 1993 and 1994.
-
Hancke, C. and Flytlie, K, Benefits of EDTA Chelation Therapy in Arteriosclerosis: A retrospective study of 470 patients, Journal of Advancement in Medicine, 1993, 6:3, 161-171.
-
Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hypotheses. 1988; 27:41-49.
-
Olszewer E, Sabbag FC, Carter JP. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc 1990; 82:173-174.
-
Hancke C, Flytie K. Benefits of EDTA chelation therapy on arteriosclerosis. J Adv Med. 1993; 6:161-172.
-
Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs. 1996; 10:78-86.
-
Perry, H. Mitchell, Schroeder, Henry A. Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazine. J Chronic Diseases, 1955, 2: 5, 520-532.
-
Schroeder, Henry A. A practical method for the reduction of plasma cholesterol in man. J Chronic Diseases, 1956, 4: 461-468.
-
Perry, Jr., and Camel, G., Some effects of CaNa2EDTA on plasma cholesterol and urinary zinc in man, in: Metal Binding in Medicine, by Marvin J. Seven and L. Audrey Johnson (eds), 1960, J.B. Lippincott Company, Philadelphia, 209-215.
-
Born, G.R., and Geurkink, T.L. Improved peripheral vascular function with low dose intravenous ethylene diamine tetraacetic acid (EDTA). Townsend Letter for Doctors. July, 1994, # 132, 722-726.
